- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: Epidermal Growth Factor Receptor Variant III
Total 66156 results
-
Beijing Tsinghua Chang Gung HospitalBeijing DCTY® Biotech Co.,Ltd.Not yet recruiting
-
AmgenCompletedGlioblastoma Multiforme | Advanced Malignant Glioma | Anaplastic AstrocytomasUnited States, Australia
-
AstraZenecaDaiichi SankyoNot yet recruitingNon-small Cell Lung CancerChina, Taiwan, Korea, Republic of, Australia
-
Juan LI, MDRecruitingNon Small Cell Lung Cancer | EGFR Exon 20 Insertion MutationChina
-
Daping Hospital and the Research Institute of Surgery...Not yet recruitingNon-Small Cell Lung Cancer Without Mutation in Epidermal Growth Factor Receptor (Disorder)
-
Institut Català d'OncologiaFundación Sociedad Española de Oncologia Médica; Instituto de Salud Carlos III and other collaboratorsRecruitingNeoplasms | Breast Cancer | HER2-positive Breast CancerSpain
-
AstraZenecaRecruitingStage II-IIIB Non-small Cell Lung CarcinomaSpain, Korea, Republic of, Philippines, Italy, United States, Malaysia, Taiwan, Thailand, Hong Kong, United Kingdom, Singapore
-
Allist Pharmaceuticals, Inc.Not yet recruiting
-
Sichuan Kelun Pharmaceutical Research Institute...RecruitingMetastatic Colorectal CancerChina
-
National Cancer Institute (NCI)Active, not recruitingMetastatic Lung Non-Small Cell Carcinoma | Stage IIIA Lung Non-Small Cell Cancer AJCC v7 | Recurrent Lung Non-Small Cell Carcinoma | Stage IIIB Lung Non-Small Cell Cancer AJCC v7 | Stage IV Lung Non-Small Cell Cancer AJCC v7 | Stage III Lung Non-Small Cell Cancer AJCC v7United States, Canada
-
H. Lee Moffitt Cancer Center and Research InstituteActive, not recruitingLung Cancer | Non-small Cell Lung Cancer | Non-small Cell Lung Cancer Metastatic | Stage IV Non-small Cell Lung Cancer | Non-small Cell Lung Cancer Stage IIIB | EGFR Negative Non-Small Cell Lung CancerUnited States
-
Hoffmann-La RocheGenentech, Inc.; Breast International GroupActive, not recruitingBreast CancerUnited States, Belgium, Canada, Australia, Austria, Bulgaria, China, Croatia, Denmark, France, Germany, Guatemala, Hungary, Ireland, Italy, Korea, Republic of, Panama, Slovenia, Spain, Taiwan, United Kingdom, Colombia, Czechia, El Salvador and more
-
Regeneron PharmaceuticalsActive, not recruitingAdvanced Non-small Cell Lung CancerUnited States
-
Hoffmann-La RocheCompleted
-
Merck Sharp & Dohme LLCActive, not recruitingBreast NeoplasmsKorea, Republic of, Germany, United States, United Kingdom, Argentina, Australia, Austria, Brazil, Canada, Chile, China, Colombia, France, Greece, Guatemala, Hungary, Ireland, Israel, Italy, Japan, Malaysia, Mexico, Netherlands, Phili... and more
-
Merck Sharp & Dohme LLCActive, not recruitingBreast CancerJapan, Poland, United States, Australia, Belgium, Brazil, Canada, China, Colombia, Costa Rica, France, Germany, Hungary, Ireland, Israel, Korea, Republic of, New Zealand, Portugal, Puerto Rico, Russian Federation, Spain, Taiwan, Ukr... and more
-
University of NebraskaNational Cancer Institute (NCI)TerminatedStage II Breast Cancer | Stage IIIA Breast Cancer | Stage IIIB Breast Cancer | Stage IIIC Breast Cancer | HER2-negative Breast CancerUnited States
-
Novartis PharmaceuticalsCompletedCarcinoma, Non-Small-Cell LungBelgium, Germany, Italy, France, Netherlands, Spain, Korea, Republic of, India, Brazil, Portugal
-
Fudan UniversityCompleted
-
National Taiwan University HospitalCompletedTumor Progression | EGFR Exon 19 MutationTaiwan
-
Spanish Lung Cancer GroupCompletedNon-Small Cell Lung CancerSpain, France, Italy
-
Hoffmann-La RocheCompletedBreast CancerItaly, Belgium, Canada, United Kingdom, Argentina, Australia, Austria, Brazil, Bulgaria, China, Croatia, Denmark, Dominican Republic, Ecuador, Estonia, Finland, France, Germany, Greece, Guatemala, Hong Kong, Hungary, Iceland, Indonesia, Irelan... and more
-
Hoffmann-La RocheCompletedBreast CancerUnited States, Canada, Denmark, France, Italy, Poland, Portugal, Spain, United Kingdom, Norway, Germany, Mexico
-
Hoffmann-La RocheCompletedBreast NeoplasmsHungary, Italy, United Kingdom, Canada, Czechia, Bulgaria, Croatia, Dominican Republic, France, Germany, Greece, Guatemala, Hong Kong, Indonesia, Ireland, Korea, Republic of, Netherlands, Panama, Peru, Poland, Portugal, Slovakia, Spain and more
-
Hoffmann-La RocheTerminatedBreast Cancer | Gastric CancerItaly, Argentina, Canada, France, Greece, Portugal, Slovakia, Brazil, Russian Federation, Spain, Germany, Serbia
-
Hoffmann-La RocheCompletedGastric CancerAustria, Belgium, Brazil, Canada, China, Croatia, Finland, Hungary, Italy, Korea, Republic of, Mexico, Poland, Spain, Turkey, United States, Kazakhstan, Peru, Russian Federation, Switzerland, Taiwan, Thailand, Germany, Japan, Malaysia, ... and more
-
Clovis Oncology, Inc.TerminatedNon-small Cell Lung CancerUnited States, Korea, Republic of, Germany, Taiwan, Australia, Hong Kong, Netherlands, Spain, France, United Kingdom, Canada, Switzerland
-
Hebei Medical UniversityUnknown
-
National Cancer Institute (NCI)CompletedGlioblastoma | Brain Cancer | Malignant Glioma | GliosarcomaUnited States
-
Hoffmann-La RocheCompletedNon-Small Cell Lung CancerUnited States, Italy, Korea, Republic of, Spain, Germany, Poland, Switzerland
-
Sidney Kimmel Comprehensive Cancer Center at Johns...Completed
-
University of ArizonaNational Cancer Institute (NCI); GlaxoSmithKlineTerminatedMale Breast Cancer | Stage II Breast Cancer | Stage IIIA Breast Cancer | Stage IIIB Breast Cancer | Recurrent Breast Cancer | Estrogen Receptor-positive Breast Cancer | Human Epidermal Growth Factor 2 Negative Carcinoma of BreastUnited States
-
Memorial Sloan Kettering Cancer CenterNational Cancer Institute (NCI); Synta Pharmaceuticals Corp.; New York University...CompletedHER2-positive Breast Cancer | Male Breast Cancer | Stage IV Breast Cancer | Stage IIIA Breast Cancer | Stage IIIB Breast Cancer | Stage IIIC Breast Cancer | Recurrent Breast CancerUnited States
-
AIO-Studien-gGmbHAstraZenecaTerminatedNSCLC | Non-squamous Non-small Cell Lung Cancer Stage II | Non-squamous Non-small Cell Lung Cancer Stage IIIA | Non-squamous Non-small Cell Lung Cancer Stage IIIB | Activating EGFR MutationGermany
-
Guangdong Provincial People's HospitalUnknownNon-small Cell Lung Cancer | Epidermal Growth Factor ReceptorChina
-
Chinese Society of Lung CancerGuangdong Provincial People's HospitalCompleted
-
Jiangsu HengRui Medicine Co., Ltd.Unknown
-
Hoffmann-La RocheCompletedNon-Squamous Non-Small Cell Lung CancerSpain, Taiwan, Japan, United States, France, Germany, Korea, Republic of, Malaysia
-
Alliance for Clinical Trials in OncologyNational Cancer Institute (NCI)Completed
-
AstraZenecaCompletedNon Small Cell Lung CancerGreece
-
Memorial Sloan Kettering Cancer CenterAscenta TherapeuticsTerminated
-
OSI PharmaceuticalsCompletedNon-small Cell Lung CancerUnited States, Hungary, Spain, Taiwan, Korea, Republic of, Italy, United Kingdom, Canada, Australia, Belgium, Germany, Austria, Poland, Romania, Argentina, France, Czech Republic, Greece, Russian Federation
-
Tongji UniversitySun Yat-sen University; Peking Union Medical College Hospital; RenJi Hospital; Guangdong... and other collaboratorsCompleted
-
AstraZenecaCompletedDiagnosis and Treatment Strategies in Patients With NSCLC With or Without EGFR Mutations. (IDENTIFY)Non-Small Cell Lung Cancer | Stage IIIB/IVArgentina
-
Boehringer IngelheimCompletedCarcinoma, Non-Small-Cell LungKorea, Republic of
-
AstraZenecaCompletedPulmonary CancerKorea, Republic of
-
Acepodia Biotech, Inc.Not yet recruitingMetastatic Solid Tumor | Locally Advanced Solid TumorUnited States
-
Hansoh BioMedical R&D CompanyNot yet recruitingNon-Squamous Non-Small Cell Lung Cancer